Protective Effects of Rutaecarpine in Cardiac Anaphylactic Injury is Mediated by CGRP

 

 Buy Article Permissions and Reprints

Abstract

Previous investigations have indicated that rutaecarpine activates the vanilloid receptor to evoke calcitonin gene-related peptide (CGRP) release. CGRP has been shown to alleviate cardiac anaphylactic injury. In the present study, the effect of rutaecarpine on cardiac anaphylaxis was examined. Challenge of presensitized guinea-pig hearts with a specific antigen caused marked decreases in coronary flow (CF), left ventricular pressure (LVP) and its derivatives (± dp/dt_max), an increase in heart rate, and prolongation of the P-R interval. Rutaecarpine (0.3 or 1 μM) markedly increased the content of calcitonin gene-related peptide (CGRP) in the coronary effluent and decreased the content of tumor necrosis factor-α (TNF-α) in myocardial tissues concomitantly with a significant improvement of cardiac function and alleviation of the extension of the P-R interval. Rutaecarpine at the concentration of 1 μM also inhibited the sinus tachycardia. The protective effects of rutaecarpine on cardiac anaphylaxis were abolished by CGRP_{8 - 37}, a selective CGRP receptor antagonist. These results suggest that the protective effects of rutaecarpine on cardiac anaphylactic injury are related to inhibition of TNF-α production by stimulation of CGRP release.

References

• 1 Dai W, Zhou F W, Song Q J, Li Y J, Deng H W, Xiong X M. Protective effects of calcitonin gene-related peptide on guinea-pig cardiac anaphylaxis.  Naunyn Schmiedebergs Arch Pharmacol. 2000;  361 161-5
  CrossrefPubMedGoogle Scholar
• 2 Rubin L E, Levi R. Protective role of bradykinin in cardiac anaphytaxis: coronary vasodilating and antirhythmic activities mediated by autocrine/paracrine mechanisms.  Circ Res. 1995;  76 434-40
  PubMedGoogle Scholar
• 3 Schuligoi R, Amann R, Donnerer J, Peskat B A. Release of calcitonin gene-related peptide in cardiac anaphylaxis.  Naunyn Schmiedebergs Arch Pharmacol. 1997;  355 224-9
  PubMedGoogle Scholar
• 4 Frangogiannis N G, Lindsey M L, Michael L H, Youker K A., Bressler R B, Mendoza L H, Spengler R N, Smith C W, Entman M L. Resident cardiac mast cells degranulate and release preformed TNF-a initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion.  Circulation. 1998;  98 699-710
  PubMedGoogle Scholar
• 5 Edmunds N J, Lal H, Woodward B. Effects of tumour necrosis factor-alpha on left ventricular function in the rat isolated perfused heart: possible mechanisms for a decline in cardiac function.  Br J Pharmacol. 1999;  126 189-96
  CrossrefPubMedGoogle Scholar
• 6 Kwon O, Lee E, Moon T C, Jung H, Lin C X, Nam K S, Baek S H, Min H K, Chang H W. Expression of cyclooxygenase-2 and pro-inflammatory cytokines induced by 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB153) in human mast cells requires NF-kappaB activation.  Biol Pharm Bull. 2002;  25 1165-8
  CrossrefPubMedGoogle Scholar
• 7 Retter A S, Frishman W H. The role of tumor necrosis factor in cardiac disease.  Heart Dis. 2001;  3 319-25
  PubMedGoogle Scholar
• 8 Hu C P, Xiao L, Deng H W, Li Y J. The cardioprotection of rutaecarpine is mediated by endogenous calcitonin related-gene peptide through activation of vanilloid receptors in guinea-pig hearts.  Planta Med. 2002;  68 705-9
  Article in Thieme ConnectPubMedGoogle Scholar
• 9 Peng J, Xiao L, Ye F, Deng H W, Li Y J. Inhibition of cardiac tumor necrosis factor-α production by CGRP-mediated ischemia preconditioning in isolated rat heart.  Eur J Pharmacol. 2000;  407 303-8
  CrossrefPubMedGoogle Scholar
• 10 Sheen W S, Tsai I L, Teng C M, Ko F N, Chen I S. Indolopyridoquinazoline alkaloids with antiplatelet aggregation activity from Zanthoxylum integrifoliolum .  Planta Med. 1996;  62 175-6
  PubMedGoogle Scholar
• 11 Hu C P, Xiao L, Deng H W, Li Y J. The depressor and vasodilator effects of rutaecarpine are mediated by calcitonin gene-related peptide.  Planta Med. 2003;  69 125-9
  Article in Thieme ConnectPubMedGoogle Scholar
• 12 Rang W Q, Du Y H, Hu C P, Ye F, Tan G S, Deng H W, Li Y J. Protective effects of calcitonin gene-related peptide-mediated evodiamine on guinea-pig cardiac anaphylaxis.  Naunyn Schmiedebergs Arch Pharmacol. 2003;  367 306-11
  PubMedGoogle Scholar
• 13 Mitsuhata H, Saitoh J, Hasome N, Takeuchi H, Horiguchi Y, Shimizu R. Nitric oxide synthase inhibition is detrimental to cardiac function and promotes bronchospasm in anaphylaxis in rabbits.  Shock. 1995;  4 143-8
  PubMedGoogle Scholar
• 14 Marone G, de Crescenzo G, Florio G, Granata F, Dente V, Genovese A. Immunological modulation of human cardiac mast cells.  Neurochem Res. 1999;  24 1195-202
  CrossrefPubMedGoogle Scholar
• 15 Bozkurt B, Kribbs S B, Clubb FJ J r, Michael L H, Didenko V V, Hornsby P J, Seta Y, Oral H, Spinale F G, Mann D L. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats.  Circulation. 1998;  97 1382-91
  CrossrefPubMedGoogle Scholar
• 16 Meldrum D R, Dinarello C A, Shames B D, Cleveland JC J r, Cain B S, Banerjee A, Meng X, Harken A H. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-alpha production. Potential ultimate effector mechanism of preconditioning.  Circulation. 1998;  98(19 Suppl) II214 - 8; discussion II218 - 9
  PubMedGoogle Scholar
• 17 Millet I, Vegnery A. The neuropeptide calcitonin gene-related peptide inhibits TNF-alpha but poorly induces IL-6 production by fetal rat.  Osteoblasts Cytokine. 1997;  9 999-1007
  PubMedGoogle Scholar
• 18 Li Y, Fiscus R R, Wu J, Yang L, Wang X. The antiproliferative effects of calcitonin gene-related peptide in different passages of cultured vascular smooth muscle cells.  Neuropeptides. 1997;  31 503-9
  CrossrefPubMedGoogle Scholar
• 19 Zhou Z H, Deng H W, Li Y J. Improvement of preservation with cardioplegic solution by nitroglycerin-induced delayed preconditioning is mediated by calcitonin gene-related peptide.  Int J Cardiol. 2001;  81 211-8
  CrossrefPubMedGoogle Scholar

Yuan-Jian Li, M.D.

Department of Pharmacology

School of Pharmaceutical Sciences

Central South University

No. 90 Xiang-Ya Road

Changsha

Hunan 410078

P. R. China

Phone: +86-731-2355078

Fax: +86-731-2650442

Email: yuan_jianli@yahoo.com